F2R and chronic obstructive pulmonary disease: PAR-1 ATAP-2 (total receptor) and PAR-1 H-111 (no active receptor) immunoreactivity was evaluated in the epithelium from the central and distal airways of HC and COPD subjects by immunohistochemistry.